Faeth Therapeutics: Funding, Investors & Team (Oct 2026)
Faeth Therapeutics is a company that relies on data and evidence to study how dietary nutrients affect tumor growth and cancer treatment. Their main goal is to customize diets according to tumor genotypes and treatment plans to enhance the results of cancer therapy. The company was established to bring innovative findings from cancer research labs into practical use, and is staffed by top researchers and clinicians in the field.
Faeth Therapeutics has raised $25.0M across 1 funding round on record, the most recent a Series A of $25.0M announced in Oct 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Faeth Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Faeth Therapeutics Funding Rounds
Faeth Therapeutics Founders and Leadership Team
Contact details for the Faeth Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Faeth Therapeutics Funding Compared to Other Biotechnology Startups
Faeth Therapeutics' latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Faeth Therapeutics in Biotechnology and San Francisco
Companies Similar to Faeth Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Faeth Therapeutics Funding FAQs
What does Faeth Therapeutics do?
Faeth Therapeutics is a company that relies on data and evidence to study how dietary nutrients affect tumor growth and cancer treatment. Their main goal is to customize diets according to tumor genotypes and treatment plans to enhance the results of cancer therapy. The company was established to bring innovative findings from cancer research labs into practical use, and is staffed by top researchers and clinicians in the field.
How much funding has Faeth Therapeutics raised?
Faeth Therapeutics has raised $25.0M across 1 round on record. The most recent is a Series A of $25.0M announced in Oct 2025.
When did Faeth Therapeutics last raise funding?
Faeth Therapeutics' most recent funding round on record is a Series A of $25.0M, announced in Oct 2025.
Who founded Faeth Therapeutics?
FundedIQ lists Oliver Maddocks (Founder) at Faeth Therapeutics.
Where is Faeth Therapeutics headquartered?
Faeth Therapeutics is based in San Francisco, California, United States.
How many employees does Faeth Therapeutics have?
Faeth Therapeutics is in the 11-50 employee band.
How does Faeth Therapeutics' funding compare to other Biotechnology startups?
Faeth Therapeutics' latest round of $25.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Faeth Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Faeth Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.